Published Paper Details:

One of the most common types of cancer in developing nations is pancreatic cancer. Up to 90% of pancreatic cancers are caused by pancreatic adenocarcinoma, and pancreatic neuroendocrine tumour, a less prevalent variety that accounts for 5% of all malignancies, are the two main types of malignant tumours of the pancreas. Pancreatic cancer continues to be one of the deadliest illnesses and demands immediate attention owing to its extremely poor overall survival rate, which claims many lives each year throughout the world. Two of the main obstacles in the fight against cancer are early detection and effective treatments. In the current study, we evaluated effective pancreatic cancer treatment methods and in-depth highlighted the most recent advancements in contemporary medication delivery methods that are centered on and generated from nanotechnology. Recent advances in drug delivery systems based on nanotechnology have aimed towards improving cellular absorption, enhance pharmacokinetics, and improve the efficacy of anti-cancer drugs. The current review provides information on recent developments about possible therapeutic targets for the treatment of cancer of the pancreas. This information may serve as a foundation for the future creation of multifunctional nano-constructions for the early diagnosis and effective treatment of pancreatic cancer.